Cargando…
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
Fingolimod is an approved treatment for relapsing–remitting multiple sclerosis (MS), and its properties in different pathways have raised interest in therapy research for other neurodegenerative diseases. Fingolimod is an agonist of sphingosine-1-phosphate (S1P) receptors. Its main pharmacologic eff...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419396/ https://www.ncbi.nlm.nih.gov/pubmed/32696271 http://dx.doi.org/10.1007/s40268-020-00316-1 |